Literature DB >> 20007266

The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells.

Michael J Metzger1, Christiana J Holguin, Ramon Mendoza, A Dusty Miller.   

Abstract

The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with prostate cancer, but a causal relationship has not been established. Here, we have used cultured fibroblast and epithelial cell lines to test the hypothesis that XMRV might have direct transforming activity but found only rare transformation events, suggestive of indirect transformation, even when the target cells expressed the human Xpr1 cell entry receptor for XMRV. Characterization of cells from three transformed foci showed that all were infected with and produced XMRV, and one produced a highly active transforming virus, presumably generated by recombination between XMRV and host cell nucleic acids. Given the sequence similarity of XMRV to mink cell focus-forming (MCF) viruses and the enhanced leukemogenic activity of the latter, we tested XMRV for related MCF-like cytopathic activities in cultured mink cells but found none. These results indicate that XMRV has no direct transforming activity but can activate endogenous oncogenes, resulting in cell transformation. As part of these experiments, we show that XMRV can infect and be produced at a high titer from human HT-1080 fibrosarcoma cells that express TRIM5alpha (Ref1), showing that XMRV is resistant to TRIM5alpha restriction. In addition, XMRV poorly infects NIH 3T3 cells expressing human Xpr1 but relatively efficiently infects BALB 3T3 cells expressing human Xpr1, showing that XMRV is a B-tropic virus and that its infectivity is regulated by the Fv1 mouse locus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007266      PMCID: PMC2812358          DOI: 10.1128/JVI.01941-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Generation of oncogenic type C viruses: rapidly leukemogenic viruses derived from C3H mouse cells in vivo and in vitro.

Authors:  U R Rapp; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  In vitro isolation of stable rat sarcoma viruses.

Authors:  S Rasheed; M B Gardner; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Generation of new mouse sarcoma viruses in cell culture.

Authors:  U R Rapp; C Todaro
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

5.  Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells.

Authors:  C M Corsaro; M L Pearson
Journal:  Somatic Cell Genet       Date:  1981-09

6.  Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus.

Authors:  R R O'Neill; C E Buckler; T S Theodore; M A Martin; R Repaske
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

7.  Differential cell killing by lymphomagenic murine leukemia viruses occurs independently of p53 activation and mitochondrial damage.

Authors:  Suparna Nanua; Fayth K Yoshimura
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

9.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants.

Authors:  U R Rapp; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

View more
  14 in total

1.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

2.  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.

Authors:  Michael J Metzger; A Dusty Miller
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Xenotropic retrovirus Bxv1 in human pancreatic β cell lines.

Authors:  Jeannette S Kirkegaard; Philippe Ravassard; Signe Ingvarsen; Marc Diedisheim; Emilie Bricout-Neveu; Mads Grønborg; Thomas Frogne; Raphael Scharfmann; Ole D Madsen; Claude Rescan; Olivier Albagli
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

4.  No evidence of xenotropic murine leukemia virus-related virus transmission by blood transfusion from infected rhesus macaques.

Authors:  Dhanya K Williams; Teresa A Galvin; Yamei Gao; Christina O'Neill; Dustin Glasner; Arifa S Khan
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

5.  Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV.

Authors:  Nattawat Onlamoon; Jaydip Das Gupta; Prachi Sharma; Kenneth Rogers; Suganthi Suppiah; Jeanne Rhea; Ross J Molinaro; Christina Gaughan; Beihua Dong; Eric A Klein; Xiaoxing Qiu; Sushil Devare; Gerald Schochetman; John Hackett; Robert H Silverman; François Villinger
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

Review 6.  The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.

Authors:  Robert H Silverman; Carvell Nguyen; Christopher J Weight; Eric A Klein
Journal:  Nat Rev Urol       Date:  2010-06-01       Impact factor: 14.432

7.  Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity.

Authors:  Andrew E Vaughan; Ramon Mendoza; Ramona Aranda; Jean-Luc Battini; A Dusty Miller
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

8.  Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease.

Authors:  Alice Rusmevichientong; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

9.  Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

Authors:  Robert A Smith; Geoffrey S Gottlieb; A Dusty Miller
Journal:  Retrovirology       Date:  2010-08-31       Impact factor: 4.602

10.  Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.

Authors:  Meera Murgai; James Thomas; Olga Cherepanova; Krista Delviks-Frankenberry; Paul Deeble; Vinay K Pathak; David Rekosh; Gary Owens
Journal:  Retrovirology       Date:  2013-03-27       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.